High-paying remote finance director jobs often involve managing accounting and financial control functions, establishing ...

Anumana, a leader in AI-powered cardiovascular diagnostics, today announced new groundbreaking clinical data presented at the American Heart Association (AHA) Scientific Sessions 2025. Among the ...

Mechelen, Belgium; November 3, 2025, 22:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) today announced that it will present new and updated data for CAR T-cell therapy candidate, GLPG51011, at the ...

Companies this past month announced many new products and services that use artificial intelligence to automate complex processes, secure data and improve care coordination and interoperability ...

PainReform Ltd. (Nasdaq: PRFX), today announced that DeepSolar, its solar energy business unit developing next-generation AI-driven solar analytics, was recently featured in a Watchlist Interview ...

MONTRÉAL, QC / ACCESS Newswire / November 6, 2025 / Valsoft Corporation Inc. ("Valsoft"), a Canadian company specializing in the acquisition and development of vertical market software businesses, is ...

Q3 2025 Management View CEO Ramy Farid reported "very solid progress during the third quarter," highlighting total revenue of ...

Discover Revvity, Inc.’s latest earnings, cloud growth, and $1B buyback. Click for my updated look at RVTY stock and why I ...

Inventory software should keep multi-location stock accurate, automate reorders, flag exceptions, and plug cleanly into your POS/ecommerce, accounting, and 3PL tools. Use this guide to match the right ...

Editorial Note: We earn a commission from partner links on Forbes Advisor. Commissions do not affect our editors' opinions or evaluations. Apps are a fundamental part of modern technology. And if ...

With nearly two decades of retail management and project management experience, Brett Day can simplify complex traditional and Agile project management philosophies and methodologies and can explain ...

Vepdegestrant is an investigational, orally bioavailable PROteolysis TArgeting Chimera (PROTAC) estrogen receptor degrader. Vepdegestrant is being developed as a potential monotherapy for ER+/HER2- ...